Literature DB >> 12045382

The nitric oxide pathway and oxidative stress in heart failure.

Charles D Searles1.   

Abstract

Chronic heart failure is associated with pathophysiologic alterations in myocardial and vascular function. Accompanying these changes are increased oxidative stress and modulation of the nitric oxide pathway. The role of the nitric oxide(.) pathway in heart failure and the effect of its interaction with reactive oxygen species are complex, with diverse pathophysiologic implications in both the heart and the peripheral vasculature. This review discusses current information regarding the nitric oxide(.) pathway in heart failure and its relationship with increased oxidative stress. Copyright 2002 CHF, Inc.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12045382     DOI： 10.1111/j.1527-5299.2002.00715.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN： 1527-5299


  8 in total

1.  Featured Article: Differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells.

Authors:  Lakeisha C Tillery; Tenille A Epperson; Satoru Eguchi; Evangeline D Motley
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-04

2.  Increased inducible nitric oxide synthase (iNOS) expression in human myocardial infarction.

Authors:  Verena Wilmes; Stefanie Scheiper; Winta Roehr; Constanze Niess; Stefan Kippenberger; Katja Steinhorst; Marcel A Verhoff; Silke Kauferstein
Journal:  Int J Legal Med       Date:  2019-03-29       Impact factor: 2.686

3.  Locomotor Muscle Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.

Authors:  Michael A Francisco; Joshua F Lee; Zachary Barrett-O'Keefe; H Jonathan Groot; Stephen M Ratchford; Kanokwan Bunsawat; Jeremy K Alpenglow; John J Ryan; Jose N Nativi; Russell S Richardson; D Walter Wray
Journal:  Hypertension       Date:  2021-11-01       Impact factor: 10.190

4.  Hypothesis: role for ammonia neutralization in the prevention and reversal of heart failure.

Authors:  Oscar H L Bing
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-03-16       Impact factor: 4.733

Review 5.  Oxidative stress and heart disease: cardiac dysfunction, nutrition, and gene therapy.

Authors:  Elliott J F Cantor; Enrico V Mancini; Rishi Seth; Xing-Hai Yao; Thomas Netticadan
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

6.  The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure.

Authors:  Koichi Narita; Eisuke Amiya; Nobutaka Kakuda; Hidehiro Kaneko; Masaru Hatano; Issei Komuro
Journal:  Diagnostics (Basel)       Date:  2020-01-27

Review 7.  Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review.

Authors:  Vincenzo Mollace; Giuseppe M C Rosano; Stefan D Anker; Andrew J S Coats; Petar Seferovic; Rocco Mollace; Annamaria Tavernese; Micaela Gliozzi; Vincenzo Musolino; Cristina Carresi; Jessica Maiuolo; Roberta Macrì; Francesca Bosco; Marcello Chiocchi; Francesco Romeo; Marco Metra; Maurizio Volterrani
Journal:  Nutrients       Date:  2021-01-17       Impact factor: 5.717

8.  Changes in gene expression patterns in postmortem human myocardial infarction.

Authors:  Verena Wilmes; Constantin Lux; Constanze Niess; Elise Gradhand; Marcel A Verhoff; Silke Kauferstein
Journal:  Int J Legal Med       Date:  2020-05-12       Impact factor: 2.686
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.